← FDA Drug Approvals (Drugs@FDA)

IRBESARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2015-12-10

Drug application

FDA Application #

ANDA203685

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRBESARTAN

Generic name

Irbesartan

Active ingredients

IRBESARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AJANTA PHARMA LTD

First approval

2015-12-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown